Oushi Baitai (Beijing) Biotechnology Co., Ltd. was established in 2023 and is a high-tech enterprise jointly founded by Peking University School of Stomatology, Dianyun Biotechnology, Maihai Materials Genomics, social capital, and dental industry elites. The company is committed to promoting the import substitution of high-value dental and orthopedic consumables based on independently developed next-generation regenerative medicine materials and 3D printing equipment platforms, and achieving leapfrog development of key technologies.
The company's first product, "Oral Bioglass Artificial Bone," originated from the 2021 National Clinical Key Specialized Technology Transformation Project. The project is led by Peking University Stomatological Hospital and brings together industry experts from Northwestern Polytechnical University, Dianyun Biotechnology, and Maihai International Institute of Materials Genomics. It was successfully completed in 2023 and has obtained three national invention patents. At present, the product has completed technological transformation and is fully responsible for industrialization promotion by Oushi Baitai.
The company always adheres to the business philosophy of "innovation first, quality oriented", and the corporate spirit of "focus, responsibility, and pragmatism". It focuses on the field of medical devices and is committed to building a high-end medical device company that integrates research and development, production, sales, and service.
